Merck & Company Inc (MRK)

Debt-to-assets ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	34,462,000	34,982,000	34,717,000	31,142,000	33,683,000	33,972,000	34,072,000	28,074,000	28,745,000	28,482,000	28,684,000	30,586,000	30,690,000	22,907,000	24,033,000	24,002,000	25,360,000	26,321,000	26,156,000	21,637,000
Total assets	US$ in thousands	117,106,000	117,532,000	112,630,000	105,849,000	106,675,000	106,727,000	104,469,000	107,796,000	109,160,000	107,081,000	107,095,000	106,668,000	105,694,000	93,494,000	90,688,000	90,847,000	91,588,000	89,800,000	90,615,000	84,913,000
Debt-to-assets ratio		0.29	0.30	0.31	0.29	0.32	0.32	0.33	0.26	0.26	0.27	0.27	0.29	0.29	0.25	0.27	0.26	0.28	0.29	0.29	0.25

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $34,462,000K ÷ $117,106,000K
= 0.29

The debt-to-assets ratio of Merck & Company Inc has shown some fluctuations over the quarters, ranging from 0.25 to 0.33. This ratio represents the proportion of the company's assets that are financed through debt. Generally, a lower debt-to-assets ratio indicates that the company relies less on debt to fund its operations and investments, which can be viewed positively as it signifies a lower financial risk and greater stability.

In the case of Merck & Company Inc, the ratio has mostly remained within a relatively narrow range between 0.25 and 0.33 over the quarters, with a slight uptrend towards the end of the observation period. While the fluctuations are not significant, it is important to monitor this ratio over time to ensure that the company's debt levels are sustainable and in line with its overall financial strategy.